David Mark Loeb MD

Pediatric Hematology & Oncology•Bronx, NY

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Associate Professor of Pediatrics; Chief, Pediatric Hematology, Oncology, and Marrow & Blood Cell Transplantation, Children's Hospital at Montefiore

Join to View Full Profile

3415 Bainbridge AveBronx, NY 10467
Phone+1 718-741-2426

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1997 - 2000
Johns Hopkins UniversityResidency, Pediatrics, 1994 - 1997
Columbia University Vagelos College of Physicians and SurgeonsClass of 1994

Certifications & Licensure

NY State Medical License 2017 - 2027
MD State Medical License 1997 - 2018
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2012-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
America's Top Doctors for Cancer Castle Connolly, 2011-2013
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Join now to see all

Clinical Trials

Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma Start of enrollment: 2004 Oct 01
Completed
Phase 2
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy Start of enrollment: 2005 Aug 15
Completed
Phase 2
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04
Completed
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Start of enrollment: 2009 Sep 01
Completed
Phase 1, Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
UNKNOWN
PHASE3
Stereotactic Radiation Therapy for Pediatric Sarcomas Start of enrollment: 2013 Nov 01
Completed
Not Applicable
Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma Start of enrollment: 2013 Aug 19
Terminated
Phase 2
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies Start of enrollment: 2015 Jul 02
Completed
Phase 2
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma Start of enrollment: 2016 Oct 25
ACTIVE_NOT_RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Pravastatin for Radiation-Induced Fibrosis of the Extremity: A Single-Center Experience.
Rachel Offenbacher, Lara Fabish, Alice Lee, Rui Yang, Bang Hoang
Pediatric Blood & Cancer. 2025-12-01
Polyamine Depletion by D,L-α-Difluoromethylornithine Inhibits Ewing Sarcoma Metastasis by Inducing Ferroptosis.
Rachel Offenbacher, Kyle W Jackson, Masanori Hayashi, Jinghang Zhang, Da Peng
Clinical Cancer Research. 2025-10-01
Cytokine Profiling of Children, Adolescents, and Young Adults Newly Diagnosed with Sarcomas Demonstrates the Role of IL-1β in Osteosarcoma Metastasis.
Laurel Kastner, William Kandalaft, Aakash Mahant Mahant, Jessica Crimella, Sydney Hakim
Cancers. 2025-09-15

Abstracts/Posters

Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...
David Loeb, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Reduced Intensity Haploidentical BMT for High Risk Solid TumorsMarch 5th, 2013

Grant Support

Targeting DKK-1 To Prevent Osteosarcoma MetastasisALBERT EINSTEIN COLLEGE OF MEDICINE2021–2026

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/david-loeb